Ontology highlight
ABSTRACT:
SUBMITTER: Maldonado EB
PROVIDER: S-EPMC7491026 | biostudies-literature | 2020 May
REPOSITORIES: biostudies-literature
Maldonado Edward B EB Parsons Scott S Chen Emerson Y EY Haslam Alyson A Prasad Vinay V
Future science OA 20200525 8
<h4>Aims patients & methods</h4>In this retrospective review, we sought to estimate the proportion of patients in the USA with advanced or metastatic cancer who are eligible for and may respond to recommended first-line cytotoxic chemotherapy based on National Comprehensive Cancer Network treatment guidelines.<h4>Results</h4>Among 609,640 patients, we estimate 479,823 (78.7%, 95% CI: 78.6-78.8%) may be eligible for cytotoxic chemotherapy while 189,159 out of 609,640 patients (31.0%, 95% CI: 30.9 ...[more]